Cargando…
A Saudi Gastroenterology Association Position Statement on the Use of Tumor Necrosis Factor-alfa Antagonists for the Treatment of Inflammatory Bowel Disease
The objective of this position statement from the Saudi Gastroenterology Association is to guide gastroenterologists on the use of tumor necrosis factor-alfa (TNF-α) antagonists for the treatment of the idiopathic inflammatory bowel diseases, Crohn's disease, and ulcerative colitis. In this art...
Autores principales: | Mosli, Mahmoud H., Al-Harbi, Othman, Feagan, Brian G., Almadi, Majid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542416/ https://www.ncbi.nlm.nih.gov/pubmed/26228361 http://dx.doi.org/10.4103/1319-3767.161635 |
Ejemplares similares
-
Saudi Gastroenterology Association Position Statement on Safety Issues Associated with the Use of Domperidone
por: Mosli, Mahmoud H., et al.
Publicado: (2014) -
Saudi Gastroenterology Association Position Statement on Privilege and Credentialing for Performing Endoscopic Retrograde Cholangiopancreatography In Saudi Arabia
por: Alharbi, Ahmad, et al.
Publicado: (2014) -
COVID-19 and endoscopy services in intermediately affected countries: a position statement from the saudi gastroenterology association
por: Almadi, Majid A., et al.
Publicado: (2020) -
The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020) -
Sedation during endoscopic procedures: a Hellenic Society of Gastroenterology Position Statement
por: Viazis, Nikolaos, et al.
Publicado: (2023)